SHAH BIMAL R. 4
4 · Anebulo Pharmaceuticals, Inc. · Filed Jun 17, 2024
Insider Transaction Report
Form 4
SHAH BIMAL R.
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-13+3,309→ 3,309 totalExercise: $2.10Exp: 2034-06-12→ Common Stock (3,309 underlying) - Award
Stock Option (right to buy)
2024-06-13+41,667→ 41,667 totalExercise: $2.10Exp: 2034-06-12→ Common Stock (41,667 underlying)
Footnotes (2)
- [F1]These stock options vest 50% on the date of the 2024 annual meeting of shareholders and 50% on the one year anniversary of the date of grant
- [F2]These stock options vest on the earlier of November 30,2024 or the date of the 2024 annual meeting of shareholders